These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 18619737

  • 1. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004.
    Messadi AA, Lamia T, Kamel B, Salima O, Monia M, Saida BR.
    Burns; 2008 Dec; 34(8):1098-102. PubMed ID: 18619737
    [Abstract] [Full Text] [Related]

  • 2. The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department.
    Thabet L, Memmi M, Turki A, Messadi AA.
    Tunis Med; 2010 May; 88(5):297-300. PubMed ID: 20517823
    [Abstract] [Full Text] [Related]

  • 3. [Evolution of antibiotic consumption in an intensive care burn department].
    Thabet L, Bousselmi K, Oueslati S, Memmi M, Ben Redjeb S, Messadi AA.
    Tunis Med; 2007 Dec; 85(12):1035-8. PubMed ID: 19170383
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS, Singh NN.
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [Abstract] [Full Text] [Related]

  • 5. [Implementation of antimicrobial resistance surveillance and antibiotic consumption in an intensive care burn department].
    Messadi AA, Thabet L, Bousselmi K, Oueslati S, Ben Redjeb S.
    Tunis Med; 2008 May; 86(5):486-9. PubMed ID: 19469305
    [Abstract] [Full Text] [Related]

  • 6. [Epidemiological profile and antibiotic susceptibility of Pseudomonas aeruginosa isolates within the burned patient hospitalized in the intensive care burn unit].
    Lamia T, Bousselmi K, Saida BR, Allah MA.
    Tunis Med; 2007 Feb; 85(2):124-7. PubMed ID: 17665658
    [Abstract] [Full Text] [Related]

  • 7. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].
    Yüce A, Yapar N, Eren Kutsoylu O.
    Mikrobiyol Bul; 2009 Apr; 43(2):195-202. PubMed ID: 19621603
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
    Al-Jasser AM, Elkhizzi NA.
    Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
    [Abstract] [Full Text] [Related]

  • 10. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran.
    Ranjbar R, Owlia P, Saderi H, Mansouri S, Jonaidi-Jafari N, Izadi M, Farshad S, Arjomandzadegan M.
    Acta Med Iran; 2011 Jun; 49(10):675-9. PubMed ID: 22071644
    [Abstract] [Full Text] [Related]

  • 11. [Pseudomonas aeruginosa: antimicrobial resistance in clinical isolates. Castellón 2004-2008].
    Pardo Serrano FJ, Tirado Balaguer MD, García Zúñiga ED, Granados Ortega J, Campos Aznar A, Moreno Muñoz R.
    Rev Esp Quimioter; 2010 Mar; 23(1):20-6. PubMed ID: 20232020
    [Abstract] [Full Text] [Related]

  • 12. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R.
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [Abstract] [Full Text] [Related]

  • 13. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M, Carbonnelle S, Avrain L, Mesaros N, Pirnay JP, Bilocq F, De Vos D, Simon A, Piérard D, Jacobs F, Dediste A, Tulkens PM, Van Bambeke F, Glupczynski Y.
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [Abstract] [Full Text] [Related]

  • 14. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.
    Mohr JF, Jones A, Ostrosky-Zeichner L, Wanger A, Tillotson G.
    Int J Antimicrob Agents; 2004 Oct; 24(4):346-51. PubMed ID: 15380259
    [Abstract] [Full Text] [Related]

  • 15. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.
    Obritsch MD, Fish DN, MacLaren R, Jung R.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4606-10. PubMed ID: 15561832
    [Abstract] [Full Text] [Related]

  • 16. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units.
    Georges B, Conil JM, Dubouix A, Archambaud M, Bonnet E, Saivin S, Lauwers-Cancès V, Cristini C, Cougot P, Decun JF, Mathe O, Chabanon G, Marty N, Seguin T, Houin G.
    Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
    Manno G, Cruciani M, Romano L, Scapolan S, Mentasti M, Lorini R, Minicucci L.
    Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of susceptibility of Pseudomonas aeruginosa isolated from a burn ward to antibiotics in vitro].
    Zhang YH, Deng SL, Liu JW.
    Zhonghua Shao Shang Za Zhi; 2005 Apr; 21(2):104-6. PubMed ID: 15938955
    [Abstract] [Full Text] [Related]

  • 19. [Pseudomonas aeruginosa: a multicentric study of antibiotic resistance (1999-2000)].
    Kalai S, Jouaihia W, Mahjoubi F, Ghozzi R, Thabet L, Ben Rejeb S, Hammami A, Kechrid A, Ben Hassen A.
    Tunis Med; 2004 Dec; 82(12):1070-4. PubMed ID: 15822507
    [Abstract] [Full Text] [Related]

  • 20. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
    Minchella A, Molinari L, Alonso S, Bouziges N, Sotto A, Lavigne JP.
    Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.